Test drug Apomivir for early flu treatment
Part of Ear, nose & throat, Infections, Lungs & breathing, Mouth & dental clinical trials.
This trial studies whether Apomivir works and is safe for people who likely have the flu and test positive for influenza A or B. You may help researchers learn if treating early can reduce flu illness and side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 20 to 65 (male or female)
- You have flu symptoms starting less than 48 hours ago, including at least one breathing symptom (like cough or sore throat) and one “whole-body” symptom (like fatigue or headache)
- Your nasal/throat swab test is positive for flu A or B
- You can follow study instructions and agree to sign consent paperwork
- You are not pregnant or breastfeeding, and you use reliable birth control if you could become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study compares antiviral medicines in adults who have early, flu-like symptoms and test positive for influenza. It aims to see which antiviral treatment works best and is safe for people treated soon after symptoms start.
This study tests a new medicine called TRX-100 to see if it can help fight the flu. Healthy volunteers will be exposed to the influenza A virus in a controlled setting to see how the medicine works.
This study looks at how your immune system (your body’s infection-fighting system) responds during and around the time of a flu illness. It’s meant to help researchers better understand immune changes in healthy adults and may guide future flu care.
This study tests an experimental antiviral pill called Onradivir for teenagers (ages 12 to 17) with uncomplicated influenza A. It aims to see if the drug can safely shorten flu symptoms and help you recover faster.
This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.
This study compares two versions of an antiviral medicine called Ingavirin to see how your body processes them and whether they are safe. Researchers will give you the medicine on an empty stomach and after eating to understand how food affects how your body absorbs it.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.